Related Experiment Videos
[Long-term results of coronary angioplasty]
1Abteilung für Kardiologie, Univ. Frankfurt a. M.
Insights
Long-term prognosis after percutaneous transluminal coronary angioplasty (PTCA) is favorable, particularly for single-vessel disease patients. Restenosis absence at six months indicates lasting PTCA success, aiding insurance risk assessment.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Context:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common intervention for coronary artery disease.
- Long-term outcomes and prognostic factors following PTCA require ongoing investigation.
- Assessing the durability of PTCA success is crucial for patient management and risk stratification.
Purpose:
- To evaluate the long-term prognosis following coronary angioplasty.
- To identify key determinants influencing long-term outcomes after PTCA.
- To establish criteria for assessing lasting PTCA success and its implications for insurance risk.
Summary:
- Recent studies indicate a favorable long-term prognosis after coronary angioplasty, especially in patients with single-vessel disease.
- Key determinants of long-term outcome include PTCA success, atherosclerosis progression, cardiac risk factors, coronary artery disease extent, and left ventricular function.
- Absence of restenosis six months post-PTCA suggests sustained success and provides valuable criteria for insurance risk assessment.
Impact:
- Provides evidence supporting favorable long-term outcomes of PTCA, particularly in specific patient groups.
- Identifies critical factors for predicting long-term success and patient prognosis after angioplasty.
- Offers practical criteria for insurance risk assessment based on objective measures of PTCA durability.
Abstract:
Recently published studies prove a favourable long term prognosis after coronary angioplasty, especially in patients with single vessel disease. PTCA success, progression of atherosclerosis, cardiac risk factors, extent of coronary artery disease and left ventricular function are determinants of the long term outcome. A lasting PTCA success can be assumed in patients without evidence of restenosis 6 months after PTCA. These observations are helpful criteria in the assessment of insurance risks.